As the world is currently swept up in the global pandemic that is the coronavirus, with immunocompromised people such as cancer patients are placed at great risk. However, there is one symptom of COVID19 that may also be a warning sign of kidney cancer.
Express reports that one of the big symptoms of coronavirus may also be associated with kidney cancer, and that is suffering from a high fever or high temperature. Kidney cancer or renal cancer, is one of the most common types of cancer in the United Kingdom, and according to Cancer Research UK, the cause of certain cancers causing fevers remains to be a mystery, but it is believed that some kinds of cancer produce toxins that result in the patient suffering from a high fever.
The organization also notes that the fever does not come and stay but rather fevers caused by cancer come in cycles. For instance, the fever will come at a certain time every day, or there would be days and weeks where there is no fever and then it would happen again.
However, symptoms may overlap, and thus a high fever can be mistaken for either coronavirus or kidney cancer or even some other condition. Therefore it is best to observe and consult a doctor to get a proper diagnosis as you will have to undergo tests to identify which condition could be causing the fever. In the case of coronavirus, it is highly advised to treat the symptoms and go under self-isolation or self-quarantine until the symptoms are better and so as not to spread the pathogen onto others. Frequent hand washing and disinfecting of items that are regularly handled is also highly advised.
Meanwhile, the search for a cure to cancer continues and there have been some breakthroughs. A previous report reveals one such breakthrough made in the quest to develop a cure. A study made by researchers from National Interest found that treating the healthy cells near the cancer cells with a drug known as small molecule inhibitors improved the effects of a range of chemotherapies, as some cancers may only be treated through chemotherapy.
In one experiment pairing the drug with chemotherapy, the researchers found that the chances of survival were 90 percent longer than just using chemotherapy. This means that the cancer cells that would resist the treatment could now be removed from the body.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 



